10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 2022

Overview

The 10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 2022 is an on-demand digital course that delivers a comprehensive and up-to-date review of the diagnosis, staging, and management of neoplastic diseases, including solid tumor and hematologic oncology. This program features lectures covering gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, alongside hematologic oncology topics.

On-demand oncology and hematology education — accessible anytime, anywhere.

Format: 41 Videos + 41 PDFs
Total size: 6.34 GB

Agenda

This program encompasses a thorough review presented in multiple sessions, reflecting the course content originally delivered live.

• Colon Cancer — Leonard B. Saltz, MD
• Melanoma — Paul B. Chapman, MD
• Prostate Cancer — Susan F. Slovin, MD, PhD
• Kidney Cancer — Robert J. Motzer, MD
• Urothelial Cancer — Gopa Iyer, MD
• Testis Cancer — Darren R. Feldman, MD
• Uterine/Cervix/Other Gynecologic Cancers — Carol Aghajanian, MD
• Ovarian Cancer — Rachel N. Grisham, MD
• Breast Cancer: Surgery — Hiram S. Cody III, MD, FACS
• Breast Cancer: Radiation Therapy — Beryl McCormick, MD, FACR
• Genetics — Zsofia K. Stadler, MD
• Small Cell Lung Cancer — W. Victoria Lai, MD
• Breast Cancer: Adjuvant Therapy — Chau T. Dang, MD
• Breast Cancer: Advanced Disease — Rachel Sanford, MD
• Breast Cancer: Hormonal Therapy — Julia Brockway-Marchello, MD
• Carcinoma of Unknown Primary — Anna M. Varghese, MD
• Hepatocellular Cancer and Cholangiocarcinoma — Ghassan K. Abou-Alfa, MD, MBA
• Pancreatic and Neuroendocrine Cancer — Eileen M. O’Reilly, MD
• Non Small Cell Lung Cancer — Gregory J. Riely, MD, PhD
• Head and Neck, Thyroid, Non-melanoma Skin Cancer — Lara A. Dunn, MD
• Anal/Rectal Cancer — Andrea Cercek, MD
• Esophageal/Gastric Cancer — David H. Ilson, MD, PhD, FACP, FASCO
• CNS Tumors — Christian Grommes, MD
• Sarcoma — Mark A. Dickson, MD
• Infectious Disease — Susan K. Seo, MD
• Mesothelioma — Marjorie G. Zauderer, MD
• Pharmacology — Mrinal M. Gounder, MD
• CAR T cells — Michael Scordo, MD
• Low Grade NHL — Andrew D. Zelenetz, MD, PhD
• CLL/SLL — Lindsey Roeker, MD
• DLBCL/MCL/BL — Paul Hamlin, MD
• HL/T Cell — Alison J. Moskowitz, MD
• Auto/Allo — Gunjan Shah, MD
• ALL — Mark Blaine Geyer, MD
• AML — Eytan Stein, MD
• MDS/MPN — Michael J. Mauro, MD
• Myeloma/Amyloid — Malin Hultcrantz
• Approach to The Bleeding Patient — Rekha Paramewaran, MD
• The Role of the New Direct Oral Anticoagulants in Practice — Simon Mantha, MD, MPH
• Thrombocytopenia, ITP and Beyond — Cy Wilkins, MD
• Sickle Cell Disease, Thalassemia — Jodi Mones, MD

Objectives

• Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers
• Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
• Prepare for ABIM examinations in medical oncology and hematology

Speakers

This course features a diverse faculty of expert clinicians and researchers specializing in oncology and hematology. Their expertise supports comprehensive, evidence-based education reflecting current standards in hematology, infectious diseases, medical oncology, radiation oncology, and surgical oncology.

Target Audience

This program is designed for medical oncology professionals including physicians, nurses, pharmacists, fellows, and residents who seek to strengthen their expertise in contemporary hematology and medical oncology practice.

Why This Topic Matters

The 10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 2022 addresses critical updates in hematology and oncology, supporting healthcare professionals in maintaining current clinical knowledge. This program’s content is aligned with specialty practice needs and facilitates ongoing professional development through MedHub Central’s on-demand educational platform.

By consolidating cutting-edge information on diagnosis, staging, and treatment of solid tumors and hematologic malignancies, this course enhances practitioners’ confidence in evidence-based decision making within hematology and oncology specialties.